Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare
Cartesian Therapeutics Inc. Price to Book Ratio 2016–2026
Price to book (P/B) ratio for Cartesian Therapeutics Inc. (RNAC): market cap divided by shareholder equity. As of September 30, 2023 it is 1.75.
From: 06/30/2016To: 03/31/2026
Stock Price
Book Value
Price to Book
Cartesian Therapeutics Inc. Price to Book Ratio — FAQ
Cartesian Therapeutics Inc. (RNAC) price to book ratio over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RNAC's price to book ratio history?
The chart and table above show Cartesian Therapeutics Inc.'s price to book ratio by year and by quarter, including the growth rate.